- Home
- AVAL vs MRUS Comparison
AVAL vs MRUS Comparison
Compare AVAL & MRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVAL
- MRUS
- Stock Information
- Founded
- AVAL 1994
- MRUS 2003
- Country
- AVAL Colombia
- MRUS Netherlands
- Employees
- AVAL N/A
- MRUS N/A
- Industry
- AVAL Commercial Banks
- MRUS Biotechnology: Pharmaceutical Preparations
- Sector
- AVAL Finance
- MRUS Health Care
- Exchange
- AVAL Nasdaq
- MRUS Nasdaq
- Market Cap
- AVAL 2.4B
- MRUS 2.7B
- IPO Year
- AVAL N/A
- MRUS 2016
- Fundamental
- Price
- AVAL $2.65
- MRUS $43.06
- Analyst Decision
- AVAL
- MRUS Strong Buy
- Analyst Count
- AVAL 0
- MRUS 13
- Target Price
- AVAL N/A
- MRUS $86.85
- AVG Volume (30 Days)
- AVAL 161.8K
- MRUS 872.0K
- Earning Date
- AVAL 05-15-2025
- MRUS 05-07-2025
- Dividend Yield
- AVAL 3.96%
- MRUS N/A
- EPS Growth
- AVAL 37.36
- MRUS N/A
- EPS
- AVAL 0.01
- MRUS N/A
- Revenue
- AVAL $2,661,902,702.00
- MRUS $36,133,000.00
- Revenue This Year
- AVAL $58.33
- MRUS $26.81
- Revenue Next Year
- AVAL $9.86
- MRUS $23.85
- P/E Ratio
- AVAL $13.34
- MRUS N/A
- Revenue Growth
- AVAL 0.20
- MRUS N/A
- 52 Week Low
- AVAL $1.94
- MRUS $33.19
- 52 Week High
- AVAL $3.32
- MRUS $61.61
- Technical
- Relative Strength Index (RSI)
- AVAL 50.83
- MRUS 51.15
- Support Level
- AVAL $2.41
- MRUS $33.19
- Resistance Level
- AVAL $2.57
- MRUS $43.46
- Average True Range (ATR)
- AVAL 0.18
- MRUS 3.53
- MACD
- AVAL 0.01
- MRUS 0.34
- Stochastic Oscillator
- AVAL 67.80
- MRUS 80.53
About AVAL Grupo Aval Acciones y Valores S.A. ADR (Each representing 20 preferred shares)
Grupo Aval Acciones y Valores SA is a Colombian financial services company. Its local operations consist of commercial banking (Banco de Bogota, Banco de Occidente, Banco Popular, and Banco AV Villas), pension fund management (Porvenir), and merchant banking (Corficolombiana). Outside Colombia, the company offers (via BAC Credomatic operations) consumer and credit card banking businesses in Central American countries (Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, and Panama) and Mexico. BAC Credomatic has key alliances with major credit card networks, such as Visa, MasterCard, American Express, and Diners Club.
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.